This inventor holds 72 USPTO granted patents and 29 published patent applications, plus 5 CIPO patents and 16 EPO patents, primarily in Amyloid Disease Treatment (CPC class A61K). Top assignees: Neuralab Limited, Elan Pharmaceuticals, Inc., Janssen Alzheimer Immunotherapy. Active years: 1988-2015.
Inventors with similar research interests:
Location History:
- Campbell, CA (US) (1988 - 1996)
- Redwood City, CA (US) (2001)
- Pacifica, CA (US) (1995 - 2010)
- Hillsborough, CA (US) (2014)
- Burlingame, CA (US) (2003 - 2015)
Company Filing History:
26 out of 28 
10 out of 202 
9 out of 23 
Years Active: 1988-2015
Areas of Expertise:
Title: The Pioneering Work of Inventor Dale Bernard Schenk
Introduction:
Dale Bernard Schenk, a prominent inventor based in Burlingame, CA, has made significant contributions in the field of medical research and antibody technologies. With an impressive portfolio of 58 patents to his name, Schenk's innovative work has paved the way for groundbreaking advancements in the treatment of diseases associated with amyloid deposits in the brain.
Latest Patents:
Among his latest patents is the development of "Hybrid amyloid-beta antibodies," which focuses on providing crystals containing specific amino acid sequences and Fab fragments to enhance the understanding of antibody-peptide interactions. Additionally, Schenk's patent on "Humanized antibodies that recognize beta amyloid peptide" showcases his commitment to improving treatment options for patients with amyloid-related diseases.
Career Highlights:
Schenk has garnered experience working with esteemed companies in the industry, including Neuralab Limited and Janssen Alzheimer Immunotherapy. His tenure at these organizations has allowed him to apply his expertise in antibody research and drug development to address critical healthcare challenges.
Collaborations:
Throughout his career, Schenk has collaborated with talented individuals such as Peter Andrew Seubert and Kate Dora Games. Together, they have synergized their skills to drive innovation and push the boundaries of medical science. Notably, Kate Dora Games has been instrumental in supporting Schenk's research endeavors as a valuable member of his team.
Conclusion:
In conclusion, Dale Bernard Schenk's relentless pursuit of excellence in medical research and antibody technologies has positioned him as a pioneering figure in the field. His patents, collaborations, and career highlights underscore his commitment to advancing healthcare solutions and improving the lives of patients worldwide.